News & Perspective

Oct 25, 2011

Oct 25, 2011

Strict meta-analysis raises questions about flu vaccine efficacy

Editor’s Note: This article covers research conducted in part by CIDRAP researchers. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.

See also: Public health groups say flu vaccine is best tool, despite limitations

Oct 18, 2011

Oct 18, 2011

Anthrax countermeasures better than in 2001, but work remains

(CIDRAP News) – If someone tried to kill Americans with Bacillus anthracis spores today, the nation would have a better medical tool chest for treating the sick and those potentially exposed than it had 10 years ago, when the anthrax letter attacks killed five people, but anthrax defenses are still a work in progress.

Aug 18, 2011

Aug 18, 2011

CDC updates flu vaccination recommendations

(CIDRAP News) – With shipments of influenza vaccine for the upcoming season arriving at healthcare providers' offices, the US Centers for Disease Control and Prevention (CDC) today released its advisory group's latest recommendations, which have a few changes that apply mainly to younger children and people who have egg allergies.

May 10, 2011

May 10, 2011

FDA approves Sanofi's intradermal flu vaccine

(CIDRAP News) – Sanofi Pasteur's intradermal influenza vaccine, which involves a shallow needle prick into the skin instead of deep into muscle tissue, has been approved by the US Food and Drug Administration (FDA), the company announced today.

Feb 23, 2011

Feb 23, 2011

ACIP urges pertussis vaccination for health workers

(CIDRAP News) – In the wake of a bad year for pertussis (whooping cough) in 2010, the federal Advisory Committee on Immunization Practices (ACIP) recommended today that healthcare personnel (HCP) get vaccinated against the disease and that employers should foot the bill.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»